![2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMSAxIiB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==)
PrescriberPoint artificial intelligence agent streamlines prior authorization workflow PrescriberPoint shared on April 21, 2026 that it is rolling out an...
1. Orforglipron (Foundayo) introduces a new oral glucagon-like peptide-1 (GLP-1) receptor agonist that can be taken without food or timing...
1. Poor housing affordability and poor housing quality were associated with the development of geriatric conditions and mortality over 5...
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These...
1. Shipping slowdowns in the Strait of Hormuz are disrupting the movement of key pharmaceutical ingredients and finished generic drugs....
Geopolitical instability in the Strait of Hormuz threatens global generic drug supply Ongoing escalations in the Strait of Hormuz have...
1. The World Health Organization has launched a global initiative to reduce the 15-to-20-year mortality gap for individuals with schizophrenia...
1. The American Lung Association has issued an urgent alert regarding “mouth taping,” warning that the practice poses severe asphyxiation...
1. The viral "Fibermaxxing" trend prioritizes high-volume whole-food fiber intake to optimize gut microbiome diversity and improve metabolic satiety. 2....
The Scan by 2 Minute Medicine® is a pharmaceutical and biotech newsletter and exclusive benefit for 2 Minute Medicine Plus...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
